Cheryl L. Weill

1.2k total citations
27 papers, 1.0k citations indexed

About

Cheryl L. Weill is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Developmental Neuroscience. According to data from OpenAlex, Cheryl L. Weill has authored 27 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 7 papers in Developmental Neuroscience. Recurrent topics in Cheryl L. Weill's work include Neuroscience and Neuropharmacology Research (7 papers), Neurogenesis and neuroplasticity mechanisms (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). Cheryl L. Weill is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Neurogenesis and neuroplasticity mechanisms (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). Cheryl L. Weill collaborates with scholars based in United States and Denmark. Cheryl L. Weill's co-authors include Arthur Karlin, Mark G. McNamee, Wendy B. Macklin, Lee L. Rubin, Stephen M. Schuetze, Gerald D. Fischbach, Raquel Valderrama, Douglas E. Brenneman, V. Bay and Akira Arimura and has published in prestigious journals such as Nature, Biochemical and Biophysical Research Communications and Annals of the New York Academy of Sciences.

In The Last Decade

Cheryl L. Weill

27 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheryl L. Weill United States 15 609 551 115 107 76 27 1.0k
Alexandra M. Parma United States 12 580 1.0× 434 0.8× 84 0.7× 43 0.4× 88 1.2× 16 1.1k
P H O'Lague United States 16 843 1.4× 858 1.6× 83 0.7× 61 0.6× 75 1.0× 18 1.2k
P Benda France 15 355 0.6× 244 0.4× 89 0.8× 47 0.4× 87 1.1× 35 716
Motoý Kuno Japan 11 1.6k 2.7× 1.1k 2.0× 69 0.6× 37 0.3× 128 1.7× 17 2.0k
Karen Schrader United States 10 1.1k 1.8× 840 1.5× 41 0.4× 46 0.4× 115 1.5× 12 1.6k
J. H. Steinbach United States 11 605 1.0× 371 0.7× 44 0.4× 110 1.0× 94 1.2× 17 989
Karin Mörl Germany 20 821 1.3× 702 1.3× 28 0.2× 110 1.0× 107 1.4× 38 1.2k
Toshifumi Takenaka Japan 20 484 0.8× 843 1.5× 28 0.2× 139 1.3× 261 3.4× 107 1.4k
Michael N. Sheridan United States 18 410 0.7× 432 0.8× 49 0.4× 24 0.2× 140 1.8× 30 1.1k
Sharon Ashworth United Kingdom 24 609 1.0× 439 0.8× 50 0.4× 75 0.7× 140 1.8× 43 1.6k

Countries citing papers authored by Cheryl L. Weill

Since Specialization
Citations

This map shows the geographic impact of Cheryl L. Weill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl L. Weill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl L. Weill more than expected).

Fields of papers citing papers by Cheryl L. Weill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl L. Weill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl L. Weill. The network helps show where Cheryl L. Weill may publish in the future.

Co-authorship network of co-authors of Cheryl L. Weill

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl L. Weill. A scholar is included among the top collaborators of Cheryl L. Weill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl L. Weill. Cheryl L. Weill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weill, Cheryl L.. (2008). Nature's Choice: What Science Reveals About the Biological Origins of Sexual Orientation. 5 indexed citations
2.
Weill, Cheryl L.. (2008). Nature's Choice. 1 indexed citations
3.
Arimura, Akira, Cheryl L. Weill, Roberto Fiore, et al.. (1994). PACAP Functions as a Neurotrophic Factora. Annals of the New York Academy of Sciences. 739(1). 228–243. 170 indexed citations
4.
Lyles, Joan M., et al.. (1993). Regulation of NCAM by growth factors in serum‐free myotube cultures. Journal of Neuroscience Research. 34(3). 273–286. 25 indexed citations
5.
Lyles, Joan M., et al.. (1992). Matrigel enhances myotube development in a serum‐free defined medium. International Journal of Developmental Neuroscience. 10(1). 59–67. 18 indexed citations
6.
Weill, Cheryl L.. (1991). Somatostatin (SRIF) Prevents Natural Motoneuron Cell Death in Embryonic Chick Spinal Cord. Developmental Neuroscience. 13(6). 377–381. 17 indexed citations
7.
Weill, Cheryl L., et al.. (1990). The HIV protein, GP120, activates nuclear protein kinase C in nuclei from lymphocytes and brain. Biochemical and Biophysical Research Communications. 166(3). 1133–1139. 20 indexed citations
8.
Mason‐Garcia, M., Cheryl L. Weill, & Barbara S. Beckman. (1990). Rapid activation by erythropoietin of protein kinase C in nuclei of erythroid progenitor cells. Biochemical and Biophysical Research Communications. 168(2). 490–497. 42 indexed citations
9.
Miller, Lawrence G., et al.. (1990). Augmentation of GABAA receptor function by chronic exposure to GABA-neutral and GABA-negative benzodiazepine ligands in cultured cortical neurons. Biochemical Pharmacology. 40(6). 1337–1344. 13 indexed citations
10.
Weill, Cheryl L., et al.. (1990). The prevention of natural motoneuron cell death by dibutyryl-cyclic GMP in the spinal cord of White Leghorn chick embryos. Developmental Brain Research. 55(1). 143–146. 4 indexed citations
11.
Miller, Lawrence G., et al.. (1989). Persistent alterations in GABAA receptor binding and function after prenatal lorazepam administration in the chick. Brain Research Bulletin. 23(3). 171–174. 8 indexed citations
12.
Miller, Lawrence G., Raynald Roy, & Cheryl L. Weill. (1989). Chronic clonazepam administration decreases gamma-aminobutyric acidA receptor function in cultured cortical neurons.. Molecular Pharmacology. 36(5). 796–802. 18 indexed citations
13.
Miller, Lawrence G., Cheryl L. Weill, & Raynald Roy. (1989). Prenatal lorazepam administration is associated with GABAA receptor alterations in late embryonic and mature chicks.. PubMed. 10(3). 517–22. 2 indexed citations
14.
Miller, Lawrence G., et al.. (1988). Lorazepam administration during embryonic development alters GABAA receptor binding and function. Developmental Brain Research. 44(2). 241–246. 7 indexed citations
15.
Weill, Cheryl L.. (1986). Cyclic nucleotide content of ciliary and dorsal root ganglia during embryonic development in the chick. Developmental Brain Research. 26(2). 305–309. 2 indexed citations
16.
Lyles, Joan M. & Cheryl L. Weill. (1986). Changes in Glucose 6-Phosphate Dehydrogenase Activity in Developing Embryonic Chick Skeletal Muscle and Spinal Cord. Developmental Neuroscience. 8(1). 44–52. 3 indexed citations
17.
Macklin, Wendy B. & Cheryl L. Weill. (1985). Appearance of Myelin Proteins during Development in the Chick Central Nervous System. Developmental Neuroscience. 7(3). 170–178. 38 indexed citations
18.
Weill, Cheryl L.. (1982). cGMP accumulation by spinal cord neurons during the period of neuromuscular junction formation. Neuroscience Letters. 30(3). 263–268. 9 indexed citations
19.
Karlin, Arthur, Cheryl L. Weill, Mark G. McNamee, & Raquel Valderrama. (1976). Facets of the Structures of Acetylcholine Receptors from Electrophorus and Torpedo. Cold Spring Harbor Symposia on Quantitative Biology. 40(0). 203–210. 109 indexed citations
20.
Weill, Cheryl L., Mark G. McNamee, & Arthur Karlin. (1974). Affinity-labeling of purified acetylcholine receptor from Torpedo californica. Biochemical and Biophysical Research Communications. 61(3). 997–1003. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026